Assessing unintended hybridization-induced biological effects of oligonucleotides.Lindow M, Vornlocher HP, Riley D, Kornbrust DJ, Burchard J, Whiteley LO, Kamens J, Thompson JD, Nochur S, Younis H, Bartz S, Parry J, Ferrari N, Henry SP, Levin AA. Nat Biotechnol. 2012 Oct 10;30(10):920-3. View Abstract

Nano Sized Multifunctional Polyplexes for Receptor Mediated SiRNA Delivery. Dohmen C, Edinger D, Froehlich T, Schreiner L, Laechelt U, Troiber C, Rädler J, Hadwiger P, Vornlocher HP, Wagner E. ACS Nano. 2012 May 30. View Abstract on PubMed

Structure-activity relationships of siRNA carriers based on sequence-defined oligo (ethane amino) amides. Froehlich T, Edinger D, Klaeger R, Troiber C, Salcher E, Badgujar N, Martin I, Schaffert D, Cengizeroglu A, Hadwiger P, Vornlocher HP, Wagner E. J Control Release. 2012; 160(3):532-541. Epub 2012 Mar 24. View Abstract on PubMed

Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing. Dohmen C, Froehlich T, Laechelt U, Roehl I, Vornlocher HP, Hadwiger P and Wagner E. Molecular Therapy–Nucleic Acids. 2012; 1, e7. View Article

Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine. Polach KJ, Matar M, Rice J, Slobodkin G, Sparks J, Congo R, Rea-Ramsey A, McClure D, Brunhoeber E, Krampert M, Schuster A, Jahn-Hofmann K, John M, Vornlocher HP, Fewell JG, Anwer K, Geick A. Mol Ther. 2012 Jan;20(1):91-100. Epub 2011 Oct 11. View Abstract on PubMed